Cargando…

Prime Time for Proteomics in Pulmonary Arterial Hypertension Risk Assessment?

Detalles Bibliográficos
Autores principales:	Singh, Navneet, Ventetuolo, Corey E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Thoracic Society 2022
Materias:	Editorials
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9851471/ https://www.ncbi.nlm.nih.gov/pubmed/35143371 http://dx.doi.org/10.1164/rccm.202201-0040ED

Ejemplares similares

Another Piece in the Estrogen Puzzle of Pulmonary Hypertension
por: Al-Naamani, Nadine, et al.
Publicado: (2020)

The Modified Borg Dyspnea Scale does not predict hospitalization in pulmonary arterial hypertension
por: Banerjee, Debasree, et al.
Publicado: (2017)

Retinal vessel changes in pulmonary arterial hypertension
por: DuPont, Mariana, et al.
Publicado: (2022)

Sexual health and health-related quality of life among women with pulmonary arterial hypertension
por: Banerjee, Debasree, et al.
Publicado: (2018)

Identifying Patients with Pulmonary Arterial Hypertension Using Administrative Claims Algorithms
por: Mathai, Stephen C., et al.
Publicado: (2019)

What is pulmonary arterial hypertension?
por: Rich, Stuart
Publicado: (2012)

The revolution of pulmonary arterial hypertension
por: Harari, Sergio
Publicado: (2016)

Proteomic analysis of pulmonary arterial hypertension
por: Qin, Xiaohan, et al.
Publicado: (2021)

Risk assessment in pulmonary arterial hypertension
por: Raina, Amresh, et al.
Publicado: (2016)

A Survey-based Estimate of COVID-19 Incidence and Outcomes among Patients with Pulmonary Arterial Hypertension or Chronic Thromboembolic Pulmonary Hypertension and Impact on the Process of Care
por: Lee, Joshua D., et al.
Publicado: (2020)

Risk Stratification in Pulmonary Arterial Hypertension: Do Not Forget the Patient Perspective
por: Humbert, Marc, et al.
Publicado: (2021)

Illuminating the Importance of Pulmonary Arterial Compliance in Pulmonary Hypertension
por: Weatherald, Jason, et al.
Publicado: (2023)

Risk assessment in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
por: Humbert, Marc, et al.
Publicado: (2019)

Upfront Combination Therapy for Pulmonary Arterial Hypertension: Time to Be More Ambitious than AMBITION
por: Cascino, Thomas M., et al.
Publicado: (2021)

Comparison of Retinal Imaging Techniques in Individuals with Pulmonary Artery Hypertension Using Vessel Generation Analysis
por: DuPont, Mariana, et al.
Publicado: (2022)

Targeting RUNX1 as a novel treatment modality for pulmonary arterial hypertension
por: Jeong, Euy-Myoung, et al.
Publicado: (2022)

Pulmonary arterial hypertension in scleroderma: care gaps in screening
por: Pope, Janet E.
Publicado: (2017)

Promises and Pitfalls of Multiomics Approaches to Pulmonary Arterial Hypertension
por: Simpson, Catherine E., et al.
Publicado: (2022)

Myocardial proteomic profile in pulmonary arterial hypertension
por: Hołda, Mateusz K., et al.
Publicado: (2020)

Integrative proteomics and phosphoproteomics in pulmonary arterial hypertension
por: Xu, Weiling, et al.
Publicado: (2019)

Pulmonary Arterial Hypertension: A Deeper Evaluation of Genetic Risk in the -Omics Era
por: Machado, Rajiv D., et al.
Publicado: (2021)

New Therapeutic Target for Pulmonary Arterial Hypertension
por: Yoon, Kyung Lim
Publicado: (2018)

A Plot TWIST in Pulmonary Arterial Hypertension
por: Misner, Kevin, et al.
Publicado: (2020)

Deconstructing the Melting Pot in Pulmonary Arterial Hypertension
por: Austin, Eric D., et al.
Publicado: (2020)

Iron deficiency in pulmonary arterial hypertension: perspectives
por: Quatredeniers, Marceau, et al.
Publicado: (2021)

New horizons in pulmonary arterial hypertension management
por: McLaughlin, Vallerie, et al.
Publicado: (2014)

Shuttling toward Improved Clinic-based Assessment of Exercise Capacity in Pulmonary Arterial Hypertension
por: Brittain, Evan L.
Publicado: (2021)

Prevalence and risk factors of pulmonary hypertension among adult patients with HIV infection in Ethiopia
por: Huluka, Dawit Kebede, et al.
Publicado: (2020)

The Evolution of Risk Assessment in Pulmonary Arterial Hypertension
por: Murthy, Sandhya, et al.
Publicado: (2021)

Against the Odds: Risk Stratification with Cardiac Magnetic Resonance Imaging in Pulmonary Arterial Hypertension
por: Richter, Manuel J., et al.
Publicado: (2020)

Pulmonary Arterial Hypertension and Sex in the Right Ventricle: It Is an Interesting Picture!
por: Thenappan, Thenappan, et al.
Publicado: (2020)

Evaluation of pulmonary arterial hypertension: invasive or noninvasive?
por: van der Laarse, A., et al.
Publicado: (2010)

REBOA: is it ready for prime time?
por: Doucet, Jay, et al.
Publicado: (2017)

Quality of life in pulmonary arterial hypertension
por: Post, M.C., et al.
Publicado: (2015)

Role of Ion Channels in the Development of Pulmonary Arterial Hypertension
por: Antigny, Fabrice
Publicado: (2022)

Udenafil as a Therapeutic Option for Pulmonary Arterial Hypertension
por: Kim, Hyung Yoon, et al.
Publicado: (2019)

Pulmonary arterial hypertension in adults with atrial septal defect
por: Toyono, Manatomo
Publicado: (2012)

A Novel Peptide for Immunomodulation in Pulmonary Arterial Hypertension
por: Grinnan, Daniel, et al.
Publicado: (2019)

Pulmonary arterial hypertension registries: past, present and into the future
por: Weatherald, Jason, et al.
Publicado: (2019)

A paradigm shift in pulmonary arterial hypertension management
por: Rubin, Lewis J., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_hshc9uiv3sub2r1tsa6q0gcutb